Learn More
We conducted a phase I dose escalation study to evaluate the safety and immunologic response to peptide immunomodulatory vaccines GL-0810 (HPV16) and GL-0817 (MAGE-A3) in HPV16 and MAGE-A3-positive(More)
BACKGROUND This study analyzed the impact of timing of percutaneous endoscopic gastrostomy (PEG) tube placement on clinical endpoints in patients undergoing concurrent chemoradiation therapy (CRT).(More)
e18521 Background: The best treatment for HIV-associated BL has not yet been defined. cART allows more aggressive treatment, including hyperCVAD. Recently, rituximab has improved outcomes in HIV(More)